// App-Quantinova.ai

1158-204 : FIBROBLAST GROWTH FACTOR 23 AS NOVEL BIOMARKER FOR EARLY RISK STRATIFICATION AFTER ST-ELEVATION MYOCARDIAL INFARCTION

Researchers

Presenter

  • Martin Reindla

Principal Investigators

  • Sebastian Reinstadlera

  • Hans-Josef Feistritzera

  • Lukas Muellera

  • Constantin Kocha

  • Agnes Mayra

  • Markus Theurla

  • Rudolf Kirchmaira

  • Gert Kluga

  • Bernhard Metzlera

Medical Centers

  • University Clinic of Radiology, Medical University of Innsbruck, Innsbruck, Austria

  • University Clinic of Internal Medicine III, Cardiology, Medical University of Innsbruck, Innsbruck, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • B-type natriuretic peptide

  • Fibroblast growth factor 23

  • High sensitivity C-reactive protein

  • N-terminal pro b-type natriuretic peptide

  • High-sensitivity cardiac troponin T

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved